FDA approves wider use for J&J Nucynta ER pain drug

 

Johnson & Johnson unit Janssen Pharmaceuticals has received U.S. regulatory approval for a wider use of its Nucynta ER painkiller, for pain from nerve damage brought on by diabetes. Read complete story at (Anna Yukhananov, Rueters)